Delwinds Insurance (NYSE:DWIN) announced in an 8-K this morning that its shareholders approved its combination with insurtech firm FOXO at a special meeting September 14.
The SPAC had already tipped on Tuesday that 99.5% of its shares were redeemed in connection with the vote. But, this will not interfere with its deal’s closing as the transaction includes $22.5 million in convertible debt, a $40 million committed equity facility and an FPA to purchase up to 3,000,000 shares.
The parties now expect to close the transaction later today, after which the combined company’s shares are expected to trade under the symbol “FOXO” beginning on September 16.
The parties announced their $297 million combination earlier this year on February 24. Minneapolis, Minnesota-based FOXO Technologies utilizes AI-driven bioinformatics and technologies to develop and commercialize epigenetic biomarkers of health and aging for the life insurance industry.
ADVISORS
- Deutsche Bank Securities acted as exclusive financial advisor to FOXO.
- RBC Capital Markets acted as Exclusive Financial Advisor to Delwinds.
- RBC Capital Markets and Cantor Fitzgerald acted as Capital Markets Advisors to Delwinds.
- Houlihan Lokey provided additional financial advice to the Delwinds board of directors.
- Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC acted as placement agents for the convertible debenture and redemption backstop.
- Mitchell Silberberg & Knupp and Stinson LLP acted as legal advisors to FOXO.
- Ellenoff, Grossman & Schole LLP acted as legal advisor to Delwinds while Lamson, Dugan and Murray LLP acted as insurance regulatory counsel to Delwinds.
- Proskauer Rose LLP is serving as legal advisor to Cohen & Company Capital Markets.
Berto Acquisition Corp. (NASDAQ:TACOU) announced the pricing of its upsized $261 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TACOU”, Wednesday, April 30, 2025. The new SPAC aims to conduct a broad search for a target but will have a particular interest in artificial intelligence, wellness, longevity,...
Lakeshore Acquisition III Corp. (NASDAQ:LCCCU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “LCCCU”, Wednesday, April 30, 2025. The new SPAC aims to conduct a broad search for a target with a team that has previously closed business combinations in the...
Churchill Capital Corp X (NASDAQ:CCCXU) has filed for a $300 million SPAC with a broad search focus, to add to the portfolio of Churchill deals. Five Churchill deals have closed (I, II, III, IV, and AltC), while V, VI and VII liquidated in the SPAC downturn. However, keep in mind that the Churchill team still...
Black Hawk Acquisition Corp (NASDAQ:BKHA) has entered into a definitive agreement to combine with biotech firm Vesicor Therapeutics at a pre-money equity value of $70 million. San Gabriel, California-based Vesicor is developing treatments utilizing extracellular vesicles as both a therapy themselves and as a delivery system for other medicines. The combined company is expected to...
At the SPAC of Dawn SPAC activity has continued to heat up as the market now has a new business combination to digest alongside two new SPACs making their debut on the Nasdaq later today. Three more new SPACs have filed their initial S-1s to eventually join them. That makes 29 SPAC IPOs and 49...